Pricing

AgeX Therapeutics Inc (AGE)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael D. West
Employees:
10
1101 MARINA VILLAGE PARKWAY, SUITE 201, ALAMEDA, CA, 94501
510-671-8370

Are you looking for this stock instead?

Stock Split History
DateRatio
2024-03-15 28:1000
AgeX Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available